Heart failure wearable trial fizzles: only 15 enrolled before shutdown

NCT ID NCT05988749

Terminated Disease control Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a wearable device and digital care plan from the American Heart Association could help people with systolic heart failure. Participants wore the device for 90 days while their care team monitored their data. The trial was terminated early and only enrolled 15 out of a planned 150 participants, so we cannot draw firm conclusions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Biofourmis Digital Platform with AHA Heart Failure CarePlans
What this could lead to: If successful, this approach could help doctors better manage heart failure patients remotely, potentially reducing hospital stays and improving medication use.
What could go wrong: The trial was terminated early and enrolled only 15 people, so results are very limited. It is unclear if the intervention works or is practical for wider use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE, SYSTOLIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE, SYSTOLIC

Contacts and locations

Locations

Parkland Health & Hospital System

Dallas, Texas, 75235, United States
UT Southwestern Medical Center

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.